Home Features Diversity Women Making History in Infectious Disease and Global Health Research

Women Making History in Infectious Disease and Global Health Research

-

For Women’s History Month, we are highlighting the many inspiring women who are making history in science and medicine!  From students to field leaders, across academia and industry, women scientists are pioneering new discoveries and leading the charge towards advances with clinical and global health impacts.

This week’s blog post features women in Infectious Disease and Global Health Research from around the world, and their work on immune responses and vaccine development against pathogens from coronavirus to tuberculosis, and beyond. Representing The University of Cape Town, The University of Hong Kong, The International Livestock Research Institute and the United States NIH, these rising stars are dedicated to finding better ways to prevent, treat and eventually eradicate the world’s greatest infectious disease threats.

Advancing Towards a Solution for Coronavirus VaccinesVideo: Advancing Towards a Solution for Coronavirus Vaccines | Kizzmekia S. Corbett: NIH Vaccine Research


See more on coronavirus and emerging infectious disease research on the Keypoint Blog


ADCC Antibodies are a Protective Immune Correlate in a Household Model of Influenza Transmission

ADCC Antibodies are a Protective Immune Correlate in a Household Model of Influenza Transmission | Sophie Valkenburg


See more influenza research talks on VKS


 

Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells are Induced by Human M. tuberculosis Infection

Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells are Induced by Human M. tuberculosis Infection | Cheleka Mpande


 

Foxp3+ Regulatory T cell Population Requires IL-4Rα Signaling to Control Inflammation During Helminth InfectionsFoxp3+ Regulatory T cell Population Requires IL-4Rα Signaling to Control Inflammation During Helminth Infections | Nada Abdel Aziz


Watch the VKS ePanel Discussion
“Helminths: New Insights from Immunity to Global Health”


 

Establishment of Vaccine Platform Technologies for African Swine Fever Virus as the First Target

Establishment of Vaccine Platform Technologies for African Swine Fever Virus as the First Target | Lucilla Steinaa


See more Vaccine Research on VKS


 

See more Women’s History Month Highlights!

Celebrating Women Making History in Biomedicine at Keystone Symposia

 

Shannon Weiman
Shannon Weiman
Shannon Weiman earned her PhD in Biomedical Sciences from the University of California, San Diego, specializing in microbiology and immunology. Prior to joining the Keystone Symposia team, she worked as a freelance writer for leaders in academic, industry and government research, including Stanford University’s Biomedical Innovation Initiative, the University of Colorado’s Biofrontiers Program, UCSF, the FDA and the American Society for Microbiology.
 

Keystone Symposia on Molecular and Cellular Biology is a 501(c)(3) nonprofit organization with a 47-year history of convening open, peer-reviewed conferences that connect the scientific community and accelerate life science discovery.